Kyoung Mi Moon Selected Research

Melanins (Melanin)

3/2018	A novel synthetic compound, (Z)-5-(3-hydroxy-4-methoxybenzylidene)-2-iminothiazolidin-4-one (MHY773) inhibits mushroom tyrosinase.
10/2017	2-(3, 4-dihydroxybenzylidene)malononitrile as a novel anti-melanogenic compound.
4/2015	Inhibition of melanogenesis by 2-[4-(5-chlorobenzo[d]thiazol-2-yl)phenoxy]-2-methylpropanoic acid (MHY908).
1/2015	(Z)-2-(Benzo[d]thiazol-2-ylamino)-5-(substituted benzylidene)thiazol-4(5H)-one Derivatives as Novel Tyrosinase Inhibitors.
10/2013	Anti-melanogenic effect of (Z)-5-(2,4-dihydroxybenzylidene) thiazolidine-2,4-dione, a novel tyrosinase inhibitor.
8/2013	The inhibitory effect of a synthetic compound, (Z)-5-(2,4-dihydroxybenzylidene) thiazolidine-2,4-dione (MHY498), on nitric oxide-induced melanogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyoung Mi Moon Research Topics

Disease

5	Insulin Resistance 08/2018 - 01/2017
5	Melanoma (Melanoma, Malignant) 03/2018 - 08/2013
4	Inflammation (Inflammations) 10/2017 - 01/2013
3	Neoplasms (Cancer) 07/2022 - 06/2020
3	Obesity 08/2018 - 01/2017
2	Pigmentation Disorders (Ito Syndrome) 04/2015 - 01/2015
1	Breast Neoplasms (Breast Cancer) 07/2022
1	Osteoporosis 06/2020
1	Osteoporotic Fractures 06/2020
1	Body Weight (Weight, Body) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Fatty Liver 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Hyperpigmentation 10/2017
1	Weight Gain 01/2017
1	Dyslipidemias (Dyslipidemia) 01/2017
1	Hyperinsulinism (Hyperinsulinemia) 01/2017
1	Hypoxia (Hypoxemia) 01/2012

Drug/Important Bio-Agent (IBA)

6	Melanins (Melanin)IBA 03/2018 - 08/2013
5	Monophenol Monooxygenase (Tyrosinase)IBA 10/2017 - 08/2013
3	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2012
3	AntioxidantsIBA 06/2022 - 01/2013
3	Insulin (Novolin)FDA Link 08/2018 - 01/2017
3	Melanocyte-Stimulating Hormones (MSH)IBA 03/2018 - 10/2013
2	ResveratrolIBA 06/2020 - 01/2018
2	InflammasomesIBA 08/2018 - 01/2017
2	(Z)- 5- (2,4- dihydroxybenzylidene)thiazolidine- 2,4- dioneIBA 10/2013 - 08/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2022
1	RNA (Ribonucleic Acid)IBA 07/2022
1	Phenobarbital (Luminal)FDA Link 07/2022
1	human ERBB2 proteinIBA 07/2022
1	maclurinIBA 06/2022
1	PolyphenolsIBA 06/2020
1	Therapeutic UsesIBA 06/2020
1	lithospermate BIBA 08/2018
1	PhosphoenolpyruvateIBA 08/2018
1	1-Methyl-3-isobutylxanthine (1 Methyl 3 isobutylxanthine)IBA 03/2018
1	SRT1720IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	LipidsIBA 01/2018
1	NAD (NADH)IBA 01/2018
1	Sirtuin 1IBA 01/2018
1	NF-kappa B (NF-kB)IBA 10/2017
1	barbituric acid (barbiturate)IBA 10/2017
1	Hormones (Hormone)IBA 01/2017
1	Betaine (C.B.B.)FDA Link 01/2017
1	propionic acid (potassium propionate)IBA 01/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017
1	ThiazolidinesIBA 09/2015
1	Carboxylic AcidsIBA 09/2015
1	CosmeticsIBA 01/2015
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 08/2013
1	UracilIBA 01/2013
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2013
1	caffeic acidIBA 01/2013
1	S-allylcysteine (allyl cysteine)IBA 01/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2013
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2013